Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases.

BMC cancer - 13 Aug 2022

Fan Ying, Dong Yue, Sun Xinyan, Wang Huan, Zhao Peng, Wang Hongbo, Jiang Xiran

Abstract excerpt

BACKGROUND: This study aimed to develop and externally validate contrast-enhanced (CE) T1-weighted MRI-based radiomics for the identification of epidermal growth factor receptor (EGFR) mutation, exon-19 deletion and exon-21 L858R mutation from MR imaging of spinal bone metastasis from primary lung adenocarcinoma. METHODS: A total of 159 patients from our hospital between January 2017 and September 2021 formed a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone Neoplasms

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Magnetic Resonance Imaging

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 35964032
DOI: 10.1186/s12885-022-09985-4
PMCID: PMC9375915

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases.PMID 35964032Read ↗

Contrast-enhanced MRI-based radiomics signatures as new markers for preoperative assessment of the EGFR mutation and subtypes from bone metastasesSemantic proximity Read ↗

Radiomics predicts the EGFR mutation and subtypes in metastatic lung adenocarcinoma: a multi-center studySemantic proximity Read ↗

Development and externally validate MRI-based nomogram to assess EGFR and T790M mutations in patients with metastatic lung adenocarcinoma.Semantic proximity Read ↗

Radiomics of Spinal Metastases Originating From Primary Nonsmall Cell Lung Cancer or Breast Cancer and Ability to Predict Epidermal Growth Factor Receptor Mutation/Ki-67 Levels.Semantic proximity Read ↗

MRI-Based Radiomics Nomogram as a Potential Biomarker to Predict the EGFR Mutations in Exon 19 and 21 Based on Thoracic Spinal Metastases in Lung Adenocarcinoma.Semantic proximity Read ↗

MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients.Semantic proximity Read ↗

Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.Semantic proximity Read ↗

A Bayesian meta-analysis on MRI-based radiomics for predicting EGFR mutation in brain metastasis of lung cancer.Semantic proximity Read ↗

Prediction of EGFR mutation status in non-small cell lung cancer based on multiparametric MRI radiomics.Semantic proximity Read ↗

Subregional radiomics analysis for the detection of the EGFR mutation on thoracic spinal metastases from lung cancer.Semantic proximity Read ↗

Prediction of EGFR Mutation Status in Non-small Cell Lung Cancer Based on Multiparametric MRI RadiomicsSemantic proximity Read ↗

Combined radiomics of primary tumour and bone metastasis improve the prediction of EGFR mutation status and response to EGFR-TKI therapy for NSCLC.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.